Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells

被引:3
|
作者
Märten, A [1 ]
Renoth, S [1 ]
von Lilienfeld-Toal, M [1 ]
Buttgereit, P [1 ]
Schakowski, F [1 ]
Glasmacher, A [1 ]
Sauerbruch, T [1 ]
Schmidt-Wolf, IGH [1 ]
机构
[1] Univ Bonn, Med Klin & Poliklin 1, D-53105 Bonn, Germany
关键词
CIK-cells; dendritic cells; idiotype; multiple myeloma; immunotherapy;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives. There are numerous reports of in vitro and in vivo usage of dendritic cells (DC) pulsed with idiotype, the tumor-specific antigen of multiple myeloma (MM), for immunotherapy of MM. Data suggest that not only T-cells, but also the innate immune system reacts against MM. Here, we examined the cytotoxic activity of cytokine-induced killer (CIK) cells against myeloma cells. This heterogeneous effector population consists of T-, NK- and NKT-cells. Design and Methods. CIK cells generated from buffy coats or blood from patients with MM were co-cultured with autologous idiotype-pulsed DC. The cytotoxic activity was investigated in lactate dehydrogenase release assays against cell lines or autologous CD138 positive cells from bone marrow. Results. CIK cells were able to lyse MM cells at low effector to target ratios. This effect was significantly enhanced by co-culturing with specifically pulsed DC (83.8% lysis at an effector to target ratio of 16:1). Using an interferon-gamma secreting MACS separation assay, the cytotoxic activity of CIK cells was enhanced to maximal lysis at the lower effector to target ratio of 5:1. High cytotoxic activity was also shown in a completely autologous setting against enriched CD138(+) cells from a patient with MM (54.4% lysis at an effector to target ratio of 6:1). Interestingly, there was no cytotoxic activity against the CD138(-) fraction of the bone-marrow. Interpretation and Conclusions. Using a heterogeneous population of effector cells, we were able to activate the innate and the adoptive immune-system against myeloma cells. CIK cells showed high lytic activity against MM cells, which could be enhanced by co-culturing with antigen-specific pulsed DC. (C) 2001, Ferrata Storti Foundation.
引用
收藏
页码:1029 / 1037
页数:9
相关论文
共 50 条
  • [1] Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after coculture with idiotype-pulsed dendritic cells.
    Märten, A
    Renoth, S
    von Lilienfeld-Toal, M
    Buttgereit, P
    Schakowski, F
    Schmidt-Wolf, IGH
    [J]. BLOOD, 2001, 98 (11) : 300B - 300B
  • [2] Induction of antitumor immunity by idiotype-pulsed dendritic cells against established multiple myeloma
    Zeis, M
    Uharek, L
    Glass, B
    Krönke, M
    Steinmann, J
    Schmitz, N
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 286 - 287
  • [3] In vivo study of adoptive immunotherapy against human cholangiocarcinoma by cytokine-induced killer cells after co-culture with tumors RNA-pulsed dendritic cells
    Somchitprasert, O
    Wongkajornsilp, A
    Hongeng, S
    Butraporn, R
    Huabprasert, S
    Wamanutajinda, V
    [J]. EXPERIMENTAL ANIMALS, 2006, 55 (03) : 154 - 331
  • [4] Immunotherapy of advanced refractory multiple myeloma with idiotype-pulsed dendritic cells (Mylovenge).
    MacKenzie, M
    Peshwa, MV
    Wun, T
    Wolf, J
    Mason, J
    Caggiano, V
    Redfern, C
    Strang, G
    Valone, F
    [J]. BLOOD, 2000, 96 (11) : 166A - 166A
  • [5] Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects
    Titzer, S
    Christensen, O
    Manzke, O
    Tesch, H
    Wolf, J
    Emmerich, B
    Carsten, C
    Diehl, V
    Bohlen, H
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) : 805 - 816
  • [6] Efficacy of idiotype-pulsed autologous dendritic cells for treatment of advanced refractory multiple myeloma.
    MacKenzie, M
    Peshwa, MV
    Wun, T
    Strang, G
    Wolf, J
    Gutheil, J
    Mason, J
    Caggiano, V
    Valone, FH
    [J]. BLOOD, 1999, 94 (10) : 122A - 122A
  • [7] Role of NKG2D in cytokine-induced killer cells against multiple myeloma cells
    Lu, Xuzhang
    Zhu, Aoshuang
    Cai, Xiaohui
    Jia, Zhuxia
    Han, Wenmin
    Ma, Lingdi
    Zhou, Min
    Qian, Keqing
    Cen, Lin
    Chen, Baoan
    [J]. CANCER BIOLOGY & THERAPY, 2012, 13 (08) : 623 - 629
  • [8] Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer A meta-analysis
    Yuan, Xin
    Zhang, An Zhi
    Ren, Yi Lin
    Wang, Xue Li
    Jiang, Chen Hao
    Yang, Lan
    Liu, Chun Xia
    Liang, Wei Hua
    Pang, Li Juan
    Gu, Wen Yi
    Li, Feng
    Hu, Jian Ming
    [J]. MEDICINE, 2021, 100 (13) : E24519
  • [9] High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells
    Garofano, Francesca
    Schmidt-Wolf, Ingo G. H.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11)
  • [10] Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
    Liu, Yan
    Mu, Ying
    Zhang, Anqi
    Ren, Shaoda
    Wang, Weihua
    Xie, Jiaping
    Zhang, Yingxin
    Zhou, Changhui
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 1897 - 1908